ArticlePharmacoEconomics2018

Novel Risk Engine for Diabetes Progression and Mortality in USA: Building, Relating, Assessing, and Validating Outcomes (BRAVO).

Hui Shao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.